CEREP - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for CEREP. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

CEREP. The Group's principal activity is to assist the pharmaceutical and biotechnology companies in their search for effective and safe drugs. The Group provides services under Clinical Services. The Group also provides services in the field of Collaboration & Drug Discovery which range from molecular modeling and custom synthesis of libraries to lead optimization. The Group's products and services are available to the customers through flexible business models, from pure "fee for service" to integrated collaborations and partnerships. The Group also provides pharmacology and ADMET data to pharma and biotech companies worldwide. Under Clinical Services, the Group offers clinical trials management and monitoring, data management, biostatistical analysis, clinical pharmacology and other drug development consulting services. The Group operates in Europe, North America and Asia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report